By Jacqueline Bell ( April 14, 2009, 12:00 AM EDT) -- In a reversal of its stance under the Bush administration, the U.S. Department of Justice this week aligned itself with the Federal Trade Commission against "pay-for-delay" settlements between branded-drug makers and their generics competitors, a move experts say could inspire courts to rethink their views of the deals....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.